Cargando…
Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations
Telomerase reactivation and immortalization are critical for human carcinoma progression. However, little is known about the mechanisms controlling this crucial step, due in part to the paucity of experimentally tractable model systems that can examine human epithelial cell immortalization as it mig...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613853/ https://www.ncbi.nlm.nih.gov/pubmed/25485586 http://dx.doi.org/10.4161/15384101.2014.954456 |
_version_ | 1782396331208212480 |
---|---|
author | Garbe, James C Vrba, Lukas Sputova, Klara Fuchs, Laura Novak, Petr Brothman, Arthur R Jackson, Mark Chin, Koei LaBarge, Mark A Watts, George Futscher, Bernard W Stampfer, Martha R |
author_facet | Garbe, James C Vrba, Lukas Sputova, Klara Fuchs, Laura Novak, Petr Brothman, Arthur R Jackson, Mark Chin, Koei LaBarge, Mark A Watts, George Futscher, Bernard W Stampfer, Martha R |
author_sort | Garbe, James C |
collection | PubMed |
description | Telomerase reactivation and immortalization are critical for human carcinoma progression. However, little is known about the mechanisms controlling this crucial step, due in part to the paucity of experimentally tractable model systems that can examine human epithelial cell immortalization as it might occur in vivo. We achieved efficient non-clonal immortalization of normal human mammary epithelial cells (HMEC) by directly targeting the 2 main senescence barriers encountered by cultured HMEC. The stress-associated stasis barrier was bypassed using shRNA to p16(INK4); replicative senescence due to critically shortened telomeres was bypassed in post-stasis HMEC by c-MYC transduction. Thus, 2 pathologically relevant oncogenic agents are sufficient to immortally transform normal HMEC. The resultant non-clonal immortalized lines exhibited normal karyotypes. Most human carcinomas contain genomically unstable cells, with widespread instability first observed in vivo in pre-malignant stages; in vitro, instability is seen as finite cells with critically shortened telomeres approach replicative senescence. Our results support our hypotheses that: (1) telomere-dysfunction induced genomic instability in pre-malignant finite cells may generate the errors required for telomerase reactivation and immortalization, as well as many additional “passenger” errors carried forward into resulting carcinomas; (2) genomic instability during cancer progression is needed to generate errors that overcome tumor suppressive barriers, but not required per se; bypassing the senescence barriers by direct targeting eliminated a need for genomic errors to generate immortalization. Achieving efficient HMEC immortalization, in the absence of “passenger” genomic errors, should facilitate examination of telomerase regulation during human carcinoma progression, and exploration of agents that could prevent immortalization. |
format | Online Article Text |
id | pubmed-4613853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-46138532015-10-29 Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations Garbe, James C Vrba, Lukas Sputova, Klara Fuchs, Laura Novak, Petr Brothman, Arthur R Jackson, Mark Chin, Koei LaBarge, Mark A Watts, George Futscher, Bernard W Stampfer, Martha R Cell Cycle Reports Telomerase reactivation and immortalization are critical for human carcinoma progression. However, little is known about the mechanisms controlling this crucial step, due in part to the paucity of experimentally tractable model systems that can examine human epithelial cell immortalization as it might occur in vivo. We achieved efficient non-clonal immortalization of normal human mammary epithelial cells (HMEC) by directly targeting the 2 main senescence barriers encountered by cultured HMEC. The stress-associated stasis barrier was bypassed using shRNA to p16(INK4); replicative senescence due to critically shortened telomeres was bypassed in post-stasis HMEC by c-MYC transduction. Thus, 2 pathologically relevant oncogenic agents are sufficient to immortally transform normal HMEC. The resultant non-clonal immortalized lines exhibited normal karyotypes. Most human carcinomas contain genomically unstable cells, with widespread instability first observed in vivo in pre-malignant stages; in vitro, instability is seen as finite cells with critically shortened telomeres approach replicative senescence. Our results support our hypotheses that: (1) telomere-dysfunction induced genomic instability in pre-malignant finite cells may generate the errors required for telomerase reactivation and immortalization, as well as many additional “passenger” errors carried forward into resulting carcinomas; (2) genomic instability during cancer progression is needed to generate errors that overcome tumor suppressive barriers, but not required per se; bypassing the senescence barriers by direct targeting eliminated a need for genomic errors to generate immortalization. Achieving efficient HMEC immortalization, in the absence of “passenger” genomic errors, should facilitate examination of telomerase regulation during human carcinoma progression, and exploration of agents that could prevent immortalization. Taylor & Francis 2014-10-29 /pmc/articles/PMC4613853/ /pubmed/25485586 http://dx.doi.org/10.4161/15384101.2014.954456 Text en © 2014 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. |
spellingShingle | Reports Garbe, James C Vrba, Lukas Sputova, Klara Fuchs, Laura Novak, Petr Brothman, Arthur R Jackson, Mark Chin, Koei LaBarge, Mark A Watts, George Futscher, Bernard W Stampfer, Martha R Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations |
title | Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations |
title_full | Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations |
title_fullStr | Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations |
title_full_unstemmed | Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations |
title_short | Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations |
title_sort | immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations |
topic | Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613853/ https://www.ncbi.nlm.nih.gov/pubmed/25485586 http://dx.doi.org/10.4161/15384101.2014.954456 |
work_keys_str_mv | AT garbejamesc immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations AT vrbalukas immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations AT sputovaklara immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations AT fuchslaura immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations AT novakpetr immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations AT brothmanarthurr immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations AT jacksonmark immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations AT chinkoei immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations AT labargemarka immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations AT wattsgeorge immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations AT futscherbernardw immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations AT stampfermarthar immortalizationofnormalhumanmammaryepithelialcellsintwostepsbydirecttargetingofsenescencebarriersdoesnotrequiregrossgenomicalterations |